Bayer Competitors and Similar CompaniesClear all
Bayer's competitors and similar companies include Astellas Pharma, AstraZeneca, Roche and Pfizer.
 Astellas Pharma Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. | |||
Founding Date | Founding Date 1863 | Founding Date 1923 | Founding Date 1999 | Founding Date 1896 | Founding Date 1849 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Vilvoorde, BE São Paulo, BR Markham, CA Beijing, CN see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | ||
Employees | Employees 88,5021% decrease | Employees 14,754 | Employees 94,300 | Employees 103,249 | Employees 81,0008% decrease |
Valuation ($) | Valuation ($) 27.1 b | Valuation ($) 20.8 b | Valuation ($) 2.7 b | Valuation ($) N/A | Valuation ($) 163.9 b |
Financial | |||||
Revenue (est.) | Revenue (est.) €45.6b (FY, 2025) | Revenue (est.) ¥2.1t (FY, 2026) | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) CHF61.5b (FY, 2025) | Revenue (est.) $62.6b (FY, 2025) |
Cost of goods | Cost of goods €14b (FY, 2025) | Cost of goods ¥213.8b (FY, 2026) | Cost of goods $4.9b (FY, 2025) | Cost of goods CHF13.1b (FY, 2025) | Cost of goods $16.1b (FY, 2025) |
Gross profit | Gross profit €32.5b (FY, 2025) | Gross profit ¥2t (FY, 2026) | Gross profit $54.2b (FY, 2025) | Gross profit CHF50.5b (FY, 2025) | Gross profit $46.5b (FY, 2025) |
Net income | Net income (€3.6b) (FY, 2025) | Net income ¥291.6b (FY, 2026) | Net income $10.2b (FY, 2025) | Net income CHF13.8b (FY, 2025) | Net income $7.8b (FY, 2025) |
Operating ⚠ | |||||
Countries | Countries 83 (FY, 2021) | Countries N/A | Countries 130 (FY, 2021) | Countries N/A | Countries 200 (FY, 2024) |
Funding | |||||
Total funding raised | Total funding raised $ 3.5b | Total funding raised N/A | Total funding raised $ 1b | Total funding raised $ 7.8b | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Astellas Pharma
HQ
Tokyo, JP
Employees
14,754
Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions.
View companyAstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View company
Roche
HQ
Basel, CH
Employees
103,249
Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.
View companyPfizer
HQ
New York, US
Employees
81,000↓ 8% decrease
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View company